Birk Venture — Full Portfolio

11 tracked investments · listed companies and verified rows first

Accession Therapeuticsaccessiontherapeutics.com inApr 2024

Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies.

BiotechHealthtechMedical Devices

Alan Parker(CSO and Founder of Trocept)inBent Jakobsen(CEO and Founder)in

Co-investorsiGlobe Partners

Algetaalgeta.comacquired by Bayer · Dec 2013 · $2.9B

Algeta was a Norwegian oncology company developing alpha-particle radiopharmaceuticals, notably Xofigo (radium-223 dichloride) for bone metastases in prostate cancer.

Co-investorsAdvent Life Sciences HealthCap Abingworth

APIM Therapeuticsapimtherapeutics.comNov 2011

APIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting peptide therapeutics that disrupt cellular stress responses and address treatment resistance in cancer.

BiotechHealthtech

Co-investorsSarsia Management AS

BerGenBiobergenbio.com

BerGenBio ASA was a company that merged with Oncoinvent ASA on 29 October 2025, with the combined entity renamed Oncoinvent.

Biotech

Co-investorsSarsia Management AS Investinor

Cortendo ABcortendo.com

BiotechRadnor, US

Ruth Thieroff-Ekerdt(Executive Officer)Robert Lutz(Executive Officer)Alexander Lindstrom(Executive Officer)Matthew Pauls(Executive Officer)

BoardEigil Stray Spetalen(Director)Espen Tidemann Jorgensen(Director)

Co-investorsHealthCap

Kloner ASkloner.no

Kloner is a Norwegian web operations and e-commerce company that designs, builds, and operates digital platforms for small and medium-sized businesses.

AI & Machine LearningDeveloper ToolsE-commerceEnterprise SoftwareSaaSOslo, NO

Rune Christensen(Founder)in

Nexteranextera.no

Nextera develops TCR-Like antibody drug candidates that target disease-specific pHLA antigens for cancer, autoimmune, and inflammatory diseases.

BiotechDeep Tech

Nordic Nanovector ASnordicnanovector.no

Norwegian clinical-stage biotech developing radiopharmaceuticals for hematological cancers; listed 2015.

Co-investorsHealthCap

PCI Biotechpcibiotech.no

PCI Biotech develops bioprocessing technologies for manufacturing viral vectors and intracellular drug delivery solutions, serving immunotherapy and dermatology applications.

Advanced ManufacturingBiotechMedical DevicesOslo, NO

Targovaxtargovax.comFeb 2012

Circio is a biotech company developing circular RNA technology (circVec) to improve AAV gene therapy expression for the treatment of genetic diseases.

BiotechDeep TechHealthtech

Co-investorsHealthCap

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Zelluna Immunotherapy

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.